Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
14.30
+0.01 (0.07%)
Jul 30, 2026, 10:55 AM CST

SHE:002393 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
412.89416.28184.53361.8393.61122.11
Depreciation & Amortization
77.7177.7181.1767.3166.1260.2
Other Amortization
2.392.390.03---
Loss (Gain) From Sale of Assets
-0.25-0.250.05-238.734.82-
Asset Writedown & Restructuring Costs
4.124.120.3715.271.21.61
Loss (Gain) From Sale of Investments
-326.75-326.75-102.84-15.97-23.96-19.25
Provision & Write-off of Bad Debts
0.020.020---
Other Operating Activities
29.9724.6119.1114.111914.08
Change in Accounts Receivable
78.8778.87-42.5617.5225.13-19.5
Change in Inventory
11.2811.28-21.728.9111.14-4.35
Change in Accounts Payable
-30.47-30.47-31.66-28.28116.9550.22
Change in Other Net Operating Assets
15.8715.875.553.492.74-0.03
Operating Cash Flow
249.46247.588.26200.01331.38196.34
Operating Cash Flow Growth
3541.44%180.41%-55.87%-39.65%68.78%157.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-34.76-37.46-53.75-61.72-40.91-88.24
Sale of Property, Plant & Equipment
2.92.930.41253.54115.270.09
Cash Acquisitions
-6.99-6.99--102--
Investment in Securities
-401.25-330.11-262.61-79.96-250.04-
Other Investing Activities
201.67204.3456.869.520.0412.04
Investing Cash Flow
-238.42-167.29-259.0919.36-155.64-76.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-24.3139.75---
Total Debt Issued
24.3124.3139.75---
Short-Term Debt Repaid
--39.75-47.19---
Long-Term Debt Repaid
--2.37-6.04-0.3-0.06-
Total Debt Repaid
-32.87-42.12-53.24-0.3-0.06-
Net Debt Issued (Repaid)
-8.56-17.81-13.49-0.3-0.06-
Issuance of Common Stock
7.5868.68-5.5521.01-
Repurchase of Common Stock
-93.06-93.06-39.59---
Common Dividends Paid
-173.06-97-121.03-54.74-54.74-18.25
Other Financing Activities
94.341.05-0.070.67--
Financing Cash Flow
-172.76-138.14-174.18-48.82-33.79-18.25

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0-00---
Net Cash Flow
-161.72-57.93-345170.54141.95101.97

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
214.7210.0434.51138.29290.47108.1
Free Cash Flow Growth
-508.58%-75.04%-52.39%168.71%-
Free Cash Flow Margin
15.85%15.09%2.58%11.99%25.33%9.90%
Free Cash Flow Per Share
0.700.680.110.450.940.35
Levered Free Cash Flow
271.0348.9288.1624.69302.38.51
Unlevered Free Cash Flow
272.550.3389.8225.16302.858.71

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
190.27190.18154.11195.53133.17126.12
Change in Working Capital
49.3649.36-94.16-3.83140.617.59